Dr Timothy Bock Jang, MD - Medicare Emergency Medicine in Torrance, CA

Dr Timothy Bock Jang, MD is a medicare enrolled "Emergency Medicine" physician in Torrance, California. He went to University Of California, San Diego School Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Emergency Medicine. He is a member of the group practice Southern California Emergency Medical Group and his current practice location is 1000 W Carson St, Torrance, California. You can reach out to his office (for appointments etc.) via phone at (310) 222-3500.

Dr Timothy Bock Jang is licensed to practice in Missouri (license number 2002023327) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487609707.

Contact Information

Dr Timothy Bock Jang, MD
1000 W Carson St,
Torrance, CA 90502-2004
(310) 222-3500
Not Available



Physician's Profile

Full NameDr Timothy Bock Jang
GenderMale
SpecialityEmergency Medicine
Experience24 Years
Location1000 W Carson St, Torrance, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Timothy Bock Jang attended and graduated from University Of California, San Diego School Of Medicine in 2000
  NPI Data:
  • NPI Number: 1487609707
  • Provider Enumeration Date: 05/24/2006
  • Last Update Date: 02/02/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 9234022930
  • Enrollment ID: I20050217000981

Medical Identifiers

Medical identifiers for Dr Timothy Bock Jang such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487609707NPI-NPPES
549918730MedicaidIL
900561735MedicaidMO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 2002023327 (Missouri)Primary
207P00000XEmergency Medicine A83407 (California)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Santa Monica - Ucla Med Ctr & Orthopaedic HospitalSanta monica, CAHospital
Lac/harbor-ucla Med CenterTorrance, CAHospital
Providence Little Co Of Mary Med Ctr San PedroSan pedro, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Southern California Emergency Medical Group468809706617

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Timothy Bock Jang allows following entities to bill medicare on his behalf.
Entity NameRegents Of The Univ Of Ca Emer Med
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104889138
PECOS PAC ID: 4284538521
Enrollment ID: O20031119001020

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more Medical News

› Verified 4 days ago

Entity NameCounty Of Los Angeles
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851363188
PECOS PAC ID: 1850296534
Enrollment ID: O20031204001218

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more Medical News

› Verified 4 days ago

Entity NameCep America - California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548667843
PECOS PAC ID: 6103739131
Enrollment ID: O20040121000458

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more Medical News

› Verified 4 days ago

Entity NameStephen R Shea Md Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942239033
PECOS PAC ID: 7416854377
Enrollment ID: O20040422001706

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more Medical News

› Verified 4 days ago

Entity NameSouthern California Emergency Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1518588433
PECOS PAC ID: 4688097066
Enrollment ID: O20200701001805

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Timothy Bock Jang is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Timothy Bock Jang, MD
1000 W Carson St,
Torrance, CA 90502-2004

Ph: (310) 222-3500
Dr Timothy Bock Jang, MD
1000 W Carson St,
Torrance, CA 90502-2004

Ph: (310) 222-3500

News Archive

20th anniversary of the international Convention on the Rights of the Child today

Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.

Research unravels molecular mechanisms of antisense oligonucleotides

Stanley T. Crooke, MD, PhD, CEO of Ionis Pharmaceuticals and recipient of the 2016 Lifetime Achievement Award from the Oligonucleotide Therapeutic Society presents a detailed look at the mechanisms that underlie antisense drug activity in the article entitled "Molecular Mechanisms of Antisense Oligonucleotides," published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

CHEST updates guidelines on therapy for pulmonary arterial hypertension

The American College of Chest Physicians announced the publication of updates to the evidence-based guidelines on therapy for pulmonary arterial hypertension

Minor stroke patients need urgent imaging

Mild stroke or transient ischemic attack results in a surprisingly high rate of disability, say researchers.

V-101 shows safety profile in treating erythema of rosacea: Clinical study

Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

Read more News

› Verified 4 days ago


Emergency Medicine Doctors in Torrance, CA

Dr. Gina L Sulmeyer, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 3330 Lomita Blvd, Torrance, CA 90505
Phone: 310-517-4785    
Dr. Manpreet Singh, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 W Carson St, Torrance, CA 90502
Phone: 310-222-3501    Fax: 310-782-1763
Ryan Gleber, MD, BS
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3330 Lomita Blvd, Torrance, CA 90505
Phone: 310-325-9110    
Dr. Daena Sarah Watcha, MD, MS
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 W Carson St, Torrance, CA 90502
Phone: 310-222-3501    Fax: 310-782-1763
Mary Sun, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3330 Lomita Blvd, Dept Of Emergency Medicine, Torrance, CA 90505
Phone: 310-717-6381    
Robert L.r. Gibbs, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 24325 Crenshaw Blvd, # 283, Torrance, CA 90505
Phone: 424-777-6642    Fax: 877-223-4535
Dr. Shannon M Stacy, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3330 Lomita Blvd, Torrance Memorial Medical Center, Torrance, CA 90505
Phone: 310-325-9110    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.